Interestingly, in this matrix, glioma stem cells were able to maintain key stemness biomarkers (e.g., Nestin), and at the same time, cells exhibited some glial differentiation and increased VEGF secretion over time. The gene discussed is VEGFA; the disease is central nervous system cancer.